US Patent 7220719 Modulation of endogenous gene expression in cells

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

72207190

Patent Inventor Names

Philip Gregory0

Andrew Snowden0

Casey C. Case0

Fyodor Urnov0

Siyuan Tan0

Albert Lai0

Date of Patent

May 22, 2007

Patent Application Number

108453840

Date Filed

May 13, 2004

Patent Citations Received

‌

US Patent 12121544 Cell therapies and methods of treatment for small-volume stroke

‌

US Patent 11965174 Adeno-associated virus vector variants for high efficiency genome editing and methods thereof

‌

US Patent 11981922 Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment

‌

US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment

‌

US Patent 11994512 Single-cell genomic methods to generate ex vivo cell systems that recapitulate in vivo biology with improved fidelity

‌

US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

‌

US Patent 12065668 RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci

...

Patent Primary Examiner

‌

John S. Brusca

Patent abstract

Disclosed herein are methods and compositions for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 7220719 Modulation of endogenous gene expression in cells

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 7220719 Modulation of endogenous gene expression in cells